Gene therapy trial aims to cut opioid use for diabetic pain
NCT ID NCT04087941
Summary
This study aimed to see if an experimental gene therapy called VM202 could safely help people with painful diabetic nerve damage reduce their use of opioid painkillers. It planned to enroll adults who were already taking stable, high doses of opioids for this pain. The main goal was to measure how much opioid use changed over six months compared to a placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAINFUL DIABETIC NEUROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Translational Pain Research, Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.